drugset / Trial / NCT06970119
A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
A Phase I/IIa clinical trial to evaluate the safety, tolerability, pharmacokinetics, radiation dosimetry, and preliminary efficacy of INR102 injection in patients with prostate cancer.
Timeline
- Start
- 2025-05-14
- Primary completion
- 2029-06-20
- Completion
- 2029-10-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INR102 | Other / unclassified | — | — |